Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Research and Innovation Action · Running

TRUSTING A TRUSTworthy speech-based AI monitorING system for the prediction of relapse in individuals with schizophrenia

Coordinator
Academisch Ziekenhuis Groningen, Netherlands
Runs
1 July 2023 to 31 December 2028
Status
Running
EU funding
€6.0m
Total cost
€6.0m
Partners
13 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101080251

What the project is doing

In the project's own words, from its summary on CORDIS.

Schizophrenia affects a staggering 21 million people worldwide, with 80% of these citizens suffering from a relapsing disease, putting their health and safety at enormous risk. Timely detection of these psychotic relapses would require very frequent contact with clinicians, which is neither desirable nor feasible. An accurate online relapse predictor could alert clinicians of subtle deterioration, which enables timely intervention and allow safe discontinuation of long-term medication, which so many affected citizens desire.

Our Consortium demonstrated that subtle alterations in speech carry a predictive signal for psychosis onset. This project will develop an AI monitoring system that leverages spoken language processing (SLP) and natural language processing (NLP) of speech recorded at home to calculate the relapse risk. The monitoring tool we develop will be validated retrospectively in a longitudinal cohort, cross-sectionally, across six languages, after which it will be tested prospectively in a multicenter randomized trial, with the end goal of improving functional and clinical outcomes of those affected by schizophrenia.

Developing such a system for exceptionally vulnerable people requires ‘buy-in’ from clinicians and mental health care service users, namely trust. A lack of trust is the biggest obstacle to the real-world implementation of a speech-based monitoring system. TRUSTING will develop a framework that systematically ensures addressing all the criteria for trustworthy AI put forward by the EU. This will ensure an empirically based and validated tool that can reliably detect pending relapse.

As the core philosophy of trustworthiness is part of every aspect of the project, it will be a system more likely to be welcomed and embraced by service users and their carers. TRUSTING generates the scientific and social foundation for disruptive technology to deliver the unmet promise of an equitable and just form of healthcare for people at risk of relapse.

Who is involved

OrganisationCityCountryRole
Academisch Ziekenhuis GroningenGroningenNetherlandsCoordinator
Swinburne University of TechnologyVictoriaAustraliaAssociatedpartner
Global Alliance of Mental Illness Advocacy Networks Europe AisblBruxelles / BrusselBelgiumParticipant
Universitat ZurichZurichSwitzerlandAssociatedpartner
Universite De GeneveGeneveSwitzerlandAssociatedpartner
Narodni Ustav Dusevniho ZdraviKlecanyCzechiaParticipant
Universidad Pompeu FabraBarcelonaSpainParticipant
Association Europeenne De PsychiatrieStrasbourgFranceParticipant
Syreon Kutato Intezet Korlatolt Felelossegu TarsasagBudapestHungaryParticipant
Royal College of Surgeons in IrelandDublin 2IrelandParticipant
Umcg Research BVGroningenNetherlandsThird party
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayParticipant
Dokuz Eylul UniversitesiAlsancak IzmirTürkiyeParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI